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ABSTRACT 
 
BACKGROUND: The co-ingestion of amino acids with a glucose drink has been shown to blunt the elevated post-
prandial glucose response. Though not entirely clear, some suggest amino acids will facilitate an incretin-driven 
insulin response that improves glucose sensitivity. Therefore, the purpose of this study is to examine the “priming” 
effect of pre-ingested amino acids on glycemic control in healthy inactive adults. We present here some preliminary 
data from 7 adults.  HYPOTHESIS: We hypothesize that the pre-ingested amino acids would attenuate the post-
prandial rise in glucose during a 75 g glucose tolerance test.  METHODS: To test this, seven healthy adults 
(Females: n =4, Males: n=3, Age 27.17 ± 4.7 y; Height 165.84 ± 9.53 cm; Weight 82.47 ± 14.63 kg; BMI 30.14 ± 
7.54 kg/m2; Lean body mass (LBM) 56.83 ± 20.56 kg; Fasting blood glucose (FBG) 87.43 ± 5.29 mg/dL) completed 
four trials in a randomized, single blinded fashion. The four trials required participants to ingest either Leucine 
(LEU), L-Isoleucine (ISO), an equal combination of LEU/ISO combined and lastly a control.  Each treatment was 
ingested 30-min prior to a 2 h 75-g oral glucose tolerance test.  The amino acid drink (200 mL) was standardized by 
the participant LBM (0.3g/kg) while the control consisted of inert stevia and non-amino acid ingredients found in 
equal amounts as other treatment mixtures (3.54 g). Venous blood samples were taken at baseline, and at 10, 30, 40, 
60, 90, 120, and 150-min post-treatment and 75 g glucose drink. Because data collection is ongoing, the researchers 
are still blinded to the composition of the amino acid drinks and thus results are presented as: Red A, Green B, 
Yellow C, and control (White D).  Plasma glucose (GLU) was analyzed using a YSI 2900 analyzer (Yellow Springs 
Instruments) and insulin (INS), glucagon (GCG), glucose-dependent insulinotropic peptide (GIP) and glucagon-like 
peptide-1 (GLP-1) concentrations were quantified by fluorescent bead-based technology (MAGPIX, Luminex xMAP 
technology). A 2-way RMANOVA was used to assess glucose data (Graphpad Software). RESULTS: Pre-ingestion 
of amino acid had no significant treatment effect on GLU compared to control (P = 0.5912).  Currently, only 2 
individuals have been analyzed for insulin, C-peptide, glucagon, GLP-1Active, and GIPTotal. However, we observed 
early and promising, non-statistical supported differences in concentrations between trials of insulin (Red A, Yellow 
C > Green B, White D), GLP-1Active (Red A, Green B, Yellow C > White D), and GIPTotal (Red A > Green B, Yellow 
C, White D).  CONCLUSION: Based on these preliminary results, it appears that pre-ingestion of an amino acid 
drink does not influence glucose control in healthy and inactive young adults.  It remains to be seen if pre-ingestion 
of the amino acids LEU and ISO, have any definitive effect on incretin secretion or subsequent insulin and glucagon 
responses.     
 
